Radiopharmaceutical model using Tc-99m-MIBI to evaluate amifostine protection against doxorubicin cardiotoxicity in rats

Basit Öğe Kaydı
dc.contributor.authorYurekli, Y.
dc.contributor.authorUnak, P.
dc.contributor.authorErtay, T.
dc.contributor.authorBiber, Z.
dc.contributor.authorMedine, I.
dc.contributor.authorTeksoz, S.
dc.date.accessioned2019-10-27T19:23:31Z
dc.date.available2019-10-27T19:23:31Z
dc.date.issued2005
dc.departmentEge Üniversitesien_US
dc.identifier.endpageS270en_US
dc.identifier.issn1619-7070
dc.identifier.startpageS270en_US
dc.identifier.urihttps://hdl.handle.net/11454/39196
dc.identifier.volume32en_US
dc.identifier.wosWOS:000208745101642en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imagingen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleRadiopharmaceutical model using Tc-99m-MIBI to evaluate amifostine protection against doxorubicin cardiotoxicity in ratsen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu